In fact, HSC activation markers collagen I, α-SMA and PDGFRβ were reduced in CLD rats receiving liraglutide, which was accompanied by amelioration in LSEC fenestrae and NO bioavailability. The gene discussed is ACTA1; the disease is congenital secretory chloride diarrhea 1.